Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test (RER D)

August 24, 2016 updated by: Nantes University Hospital

In order to identify the responding patients with vascular filling test, this research aims to compare the performance of the increased flow in the femoral artery to the performance of the blood pressure increase.

The reference measurement will increase cardiac output measured by ultrasound.

Study Overview

Detailed Description

It is notable that in the intensive care patient, the ultrasound measurement of cardiac flow is not always possible, especially in case of mechanical ventilation, often responsible for air interposed between the ultrasound probe and the heart, thus stopping the ultrasound. Use the blood pressure increase as a reflection of the increase in cardiac flow induced by fluid replacement is not a fully satisfactory alternative since its performance is at best just acceptable.

Flow measurement in the femoral artery could be an attractive alternative to the cardiac output measurement as:

  • It is easy: the femoral vascular ultrasound is booming with resuscitators, including the laying of intravascular catheter or thrombosis diagnosis.
  • It is painless: it is based on the application of the ultrasound probe on the root of the thigh for less than 5 minutes.
  • It is not subject to limitations echogenicity by interposition of air (except in exceptional circumstances)
  • It measures the same physiological parameter (arterial flow) as measuring ultrasound cardiac output (based on measurement of the flow at the outflow tract of the left ventricle).

Pathophysiology study, multicenter (conducted in three French ICUs), open, prospective in order to evaluate the flow doppler from the femoral artery as a reflection of cardiac flow in a vascular fluid test in patient with signs of acute circulatory failure in intensive care unit.

Study Type

Observational

Enrollment (Anticipated)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

One hundred and twenty adult patients hospitalized in one of the participating ICUs, will be included (see the justification required number of subjects in "statistics") if

  • They are already carrying an intra-arterial catheter (femoral or radial).
  • They exhibit acute circulatory failure signs (see below)
  • The doctor in charge prescribed a vascular fluid replacement, regardless of the purposes of the study:

    • vascular fluid replacement
    • initiation or catecholamine
    • or increase (> 10%) of catecholamine dosage.

Description

Inclusion Criteria:

Patient hospitalized in intensive care and affiliated to a social security system

  • Intra-arterial catheter already in place and operational
  • Stability blood pressure for 5 min (no change in mean arterial pressure> 10%, no increase in dose catecholamine)
  • Presence of at least one sign of acute circulatory failure from:

    • Low blood pressure (mean arterial pressure <65 mmHg and / or systolic <90 mmHg)
    • tachycardia> 120 bpm without other obvious cause a circulatory failure
    • Oliguria <1 ml / kg during the last hour suggestive of circulatory failure
    • blood Hyperlactataemia> 2 mmol / l without other obvious cause a systemic circulatory failure (lactate will not be measured for the purposes of the study)
    • Smear
    • ongoing catecholamine Administration
    • Another sign justifying, according to the doctor in charge, vascular filling test (capillary refill time elongated, others ...)
  • The doctor in charge has prescribed a fluid loading test, regardless of the needs of the study.

Non inclusion criteria:

Clear contraindication to the femoral artery Doppler (wound or burn the groin, for example)

  • Complete occlusion of the femoral artery or 2 of the aorta requiring or having required a vascular bypass
  • Pregnant woman
  • Minor
  • Major Trust

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
In the intensive care patient of acute circulatory failure signs, assess the increase of the femoral arterial flow (specifically its full-time speed, ΔRVAFitv measured by Doppler ultrasound) to identify responders this fluid replacement.
Time Frame: First patient enrollment: april 2014 - Study duration: 24 month - Patient follow-up: 30 minutes
First patient enrollment: april 2014 - Study duration: 24 month - Patient follow-up: 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

August 22, 2016

First Submitted That Met QC Criteria

August 24, 2016

First Posted (Estimate)

August 25, 2016

Study Record Updates

Last Update Posted (Estimate)

August 25, 2016

Last Update Submitted That Met QC Criteria

August 24, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RC13_0486

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Circulatory Failure

Clinical Trials on Doppler measurement of blood flow in the outflow tract of the left ventricle and the femoral artery,Reading blood pressures displayed on the monitor.

Subscribe